00395nam a2200121Ia 4500008004100000245013400041260001700175260000900192300000800201650002300209650001200232856002900244170516s9999    xx            000 0 und d  aTheranostic Nanoparticles Carrying Doxorubicin Attenuate Targeting Ligand Specific Antibody Responses Following Systemic Delivery  bTheranostics  c2015  a5:1  xMedical Technology  xMedtech  uhttp://www.thno.org/v5i1